Abnormalities, Multiple - 435 Studies Found
| Completed |
: Reproduction and Survival After Cardiac Defect Repair :
|
| Completed |
: Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances : Sleep Disturbances in Smith-Magenis Syndrome : 2017-03-16 : Other: Data collection of sleep disturbances in individuals with SMS Data related to Smith-Magenis syndr |
| Completed |
: Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) : Confirmed Genetic Diagnosis of Prader-Willi Syndrome : 2017-04-03 :
|
| Completed |
: Rate of Progression in USH2A Related Retinal Degeneration :
: 2017-05-04 |
| Completed |
: Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years : Prader-Willi Syndrome : 2017-03-10 :
|
| Completed |
: Evaluation of Autonomic Function in Individuals With Cornelia de Lange Syndrome (CdLS) : Cornelia de Lange Syndrome : 2016-11-16 : Other: Autonomic Dysfunction Testing The participants with CdLS will complete the COMPASS-31 survey and |
| Completed |
: Single Dose Pharmacokinetic (PK) Study :
: 2017-04-06 : Drug: OV101 Single-dose 5 mg OV101 Other Name: Gabox |
| Not yet recruiting |
: Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory : Prader-Willi Syndrome : 2017-03-23 : Behavioral: Listening Project Protocol The filtered music intervention will consist of listening to comp |
| Completed |
: A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome : Barth Syndrome : 2017-03-21 : Drug: Elamipretide 40 mg daily subcutaneous injection for 12 weeks |
| Completed |
: Study of ARQ 092 in Patients With Overgrowth Diseases and Vascular Anomalies :
: Drug: ARQ 092 Subjects will receive ARQ 092 orally at the dose level and administration schedule specifi |